Yu Huibin, Resch Wolfgang, Cotter Catherine A, Xiao Wei, Karamanolis Tase, Belghith Ahmed A, Ignacio Maxinne A, Earl Patricia L, Cohen Gary H, Moss Bernard
Laboratory of Viral Diseases, NIAID, NIH, Bethesda MD, USA.
Center for Information Technology, NIH, Bethesda MD, USA.
bioRxiv. 2025 May 7:2025.05.07.652617. doi: 10.1101/2025.05.07.652617.
The increased incidence of mpox emphasizes a need for new and improved vaccines. Poxviruses rely on a highly conserved but poorly characterized 11-protein entry-fusion complex (EFC), providing numerous potential targets. Here, we demonstrate that antibodies induced by six of 10 EFC proteins are neutralizing. Protein targets of the neutralizing and non-neutralizing antibodies are located within discrete regions of a model of the EFC predicted by AlphaFold3. Two newly identified targets, A16 and G9, at the apex of the EFC induced cross-neutralizing orthopoxvirus antibodies and protected female mice against a lethal VACV infection. Unexpectedly, antibodies to A16 and G9 were not detected following infection by attenuated or pathogenic VACV, likely due to physical sequestration of the proteins in the viral membrane. Our findings provide a model for the physical, immunogenic and antigenic structure of the EFC, new immunogens for incorporation into recombinant vaccines and suggest a novel poxvirus immune evasion strategy.
猴痘发病率的增加凸显了对新型和改进疫苗的需求。痘病毒依赖于一种高度保守但特征不明的由11种蛋白质组成的进入融合复合体(EFC),这提供了众多潜在靶点。在此,我们证明了10种EFC蛋白中的6种所诱导的抗体具有中和作用。中和抗体和非中和抗体的蛋白质靶点位于由AlphaFold3预测的EFC模型的离散区域内。EFC顶端的两个新确定的靶点A16和G9诱导了交叉中和正痘病毒抗体,并保护雌性小鼠免受致死性痘苗病毒(VACV)感染。出乎意料的是,减毒或致病性VACV感染后未检测到针对A16和G9的抗体,这可能是由于这些蛋白质在病毒膜中被物理隔离。我们的研究结果提供了EFC的物理、免疫原性和抗原结构模型,为重组疫苗提供了新的免疫原,并提示了一种新的痘病毒免疫逃避策略。